Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

2485 ARTÍCULOS , VIENDO DEL 796 AL 810

Exercise-induced modulation of miRNAs and gut microbiome: a holistic approach to neuroprotection in Alzheimer's disease

Wang R, Li J, Li X, Guo Y, Chen P, Peng T.

Rev Neurosci. 2025 May 7;36(7):717-747. doi: 10.1515/revneuro-2025-0013. Print 2025 Oct 27.

Let-7 Family as a Mediator of Exercise on Alzheimer's Disease

Ke S, Liu Z, Wan Y.

Cell Mol Neurobiol. 2025 May 19;45(1):43. doi: 10.1007/s10571-025-01559-9.

Gut Microbiota and Alzheimer Disease

Huarcaya LRD.

Acta Neurol Taiwan. 2025 Jan 1;34(1):1-12. doi: 10.4103/ANT.ANT_113_0046. Epub 2025 Mar 28.

Curcumin's multi-target mechanisms in the treatment of Alzheimer's disease and creative modification techniques

Meng X, Gong Y, Xiao F, Cao Z, Zhuang Z, Yi X, Wang J, Feng R, Gong C, Ni P.

J Alzheimers Dis. 2025 Jul;106(2):410-426. doi: 10.1177/13872877251344188. Epub 2025 Jul 1.

Protective genetic variants against Alzheimer's disease

Marino C, Malotaux V, Giudicessi A, Aguillon D, Sepulveda-Falla D, Lopera F, Quiroz YT.

Lancet Neurol. 2025 Jun;24(6):524-534. doi: 10.1016/S1474-4422(25)00116-4.

Falls in people with Alzheimer's disease: Exploring the role of inhibitory control

Wells M, Alty J, Hinder MR, St George RJ.

Neurosci Biobehav Rev. 2025 Aug;175:106228. doi: 10.1016/j.neubiorev.2025.106228. Epub 2025 May 22.

Navigating the introduction of anti-amyloid therapy in Europe: a position statement by individual members of the EADC

Frederiksen KS, Boada M, Dubois B, Engelborghs S, Frisoni GB, Georges J, Hort J, Jönsson L, Kramberger MG, Ousset PJ, Scarmeas N, Schmidt R, Schott JM, Spiro L, Waldemar G, Winblad B, Jessen F, Frölich L.

Alzheimers Res Ther. 2025 May 24;17(1):116. doi: 10.1186/s13195-025-01766-y.

[Prospects for treating Alzheimer's disease]

Vakhnina NV, Novikov DK, Vekhova KA, Zhuk AM, Klimanovich DL, Isaikin AI, Zakharov VV.

Zh Nevrol Psikhiatr Im S S Korsakova. 2025;125(4. Vyp. 2):54-60. doi: 10.17116/jnevro202512504254.

Genetics and Epigenetics of Alzheimer's Disease: Understanding Pathogenesis and Exploring Therapeutic Potential

Tiwari P, Dwivedi R, Kaushik M, Tripathi M, Dada R.

J Mol Neurosci. 2025 May 30;75(2):72. doi: 10.1007/s12031-025-02363-2.

Insulin resistance: fueling oxidative stress and neurodegeneration

Chamorro LB, Zulli B, Barone E.

J Neural Transm (Vienna). 2025 Oct;132(10):1567-1586. doi: 10.1007/s00702-025-02956-6. Epub 2025 May 31.

The role of mitochondrial dysfunction in the pathogenesis of Alzheimer's disease and future strategies for targeted therapy

Li X, Wu Z, Si X, Li J, Wu G, Wang M.

Eur J Med Res. 2025 May 31;30(1):434. doi: 10.1186/s40001-025-02699-w.

Targeting Alzheimer's disease pathology: influence of nano-based drug delivery systems loaded with a combination of herbal and synthetic drugs

Mumtaz, Unnithan D, Bano A, Chauhan APS, Ali J, Khan MA.

Expert Opin Drug Deliv. 2025 Aug;22(8):1155-1170. doi: 10.1080/17425247.2025.2513440. Epub 2025 Jun 18.

Large language models for Alzheimer's disease drug discovery

Alkam T, Tarshizi E, Van Benschoten AH.

J Alzheimers Dis. 2025 Aug;106(3):799-822. doi: 10.1177/13872877251346890. Epub 2025 Jun 2.

CD2AP at the junction of nephropathy and Alzheimer's disease

Vandal M, Janmaleki M, Rea I, Gunn C, Hirai S, Biernaskie J, Chun J, Gordon G, Shaw A, Sanati-Nezhad A, Pfeffer G, Calon F, Nguyen MD.

Mol Neurodegener. 2025 Jun 4;20(1):63. doi: 10.1186/s13024-025-00852-x.

Thioredoxin-interacting protein: an emerging target for Alzheimer's disease

Patil R, Parab SB, Bhatt LK.

Eur J Pharmacol. 2025 Sep 5;1002:177806. doi: 10.1016/j.ejphar.2025.177806. Epub 2025 Jun 4.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias